Karo Pharma Aktiebolag

(KARBF)

By |

Profile

Karo Pharma AB is a Sweden based healthcare corporation. It is primarily engaged in the business activity of developing and marketing products to pharmacies and directly to the healthcare sector. The trademarks of the firm are BabySlide, Ibux, Paracet, Plantur 39, Vagisan, Triolif, Dosett, Allevo, Mabs compression, and Swereco. The projects of the companies are RORgamma; Multiple sclerosis and cancer; and T268A common cold spray. It operates in the segment of research and development for drug discovery. The company carries its business operations in Sweden and internationally, of which majority of the revenue is generated from the Sweden and Norway.

Contact Information

Website: www.karopharma.se
Email: investor@karobio.se
Main Phone: +46 103302310
Address: Nybrokajen 7
Address 2: 8th Floor, Novum
City / Town: Stockholm
Country: SWE
Postal Code: 111 48

Issuer Information

Exchange: GREY
Employees: 91
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 4.00 $ 0. (0.00%)
Last Price 4.00 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 4.00
Last Trade Volume 0 52 Wk Hi 4.00 52 Wk Low 3.95
Market Cap 647.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 161,867,792.00 EPS (TTM) 0.45 PE Ratio 7.90 Exchange Greys